Owner Novartis AG

Inventors Baettig, Urs; Bala, Kamlesh Jagdis; Budd, Emma; Edwards, Lee; Howsham, Catherine; Hughes, Glyn; Legrand, Darren Mark; Spiegel, Katrin

Agent Davies Collison Cave

Pub. Number AU-A-2011229022

PCT Pub. Number WO2011/113894

Priority 61/315,509 19.03.10 US; 61/441,853 11.02.11 US

Filing date 17 March 2011

Wipo publication date 22 September 2011

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/443

A61P 11/12 Drugs for disorders of the respiratory system

C07D 241/28 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms